These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 34544179)
1. COVID-19 Presented with Deep Vein Thrombosis in a Patient with Paroxysmal Nocturnal Haemoglobinuria. Pravdic Z; Mitrovic M; Bogdanovic A; Virijevic M; Sabljic N; Pantic N; Vukovic NS Hamostaseologie; 2021 Oct; 41(5):397-399. PubMed ID: 34544179 [TBL] [Abstract][Full Text] [Related]
2. Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report. Schüller H; Klein F; Lübbert M; Prager EP Ann Hematol; 2021 Mar; 100(3):841-842. PubMed ID: 33170342 [No Abstract] [Full Text] [Related]
3. COVID-19 infection in patients on anti-complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience. Pike A; Muus P; Munir T; Mitchell L; Arnold L; Riley K; Houghton N; Forrest B; Gachev J; Hillmen P; Griffin M Br J Haematol; 2020 Oct; 191(1):e1-e4. PubMed ID: 32945525 [No Abstract] [Full Text] [Related]
4. Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial. Risitano AM; Röth A; Soret J; Frieri C; de Fontbrune FS; Marano L; Alashkar F; Benajiba L; Marotta S; Rozenberg I; Milojevic J; End P; Nidamarthy PK; Junge G; Peffault de Latour R Lancet Haematol; 2021 May; 8(5):e344-e354. PubMed ID: 33765419 [TBL] [Abstract][Full Text] [Related]
5. How I treat paroxysmal nocturnal hemoglobinuria. Brodsky RA Blood; 2021 Mar; 137(10):1304-1309. PubMed ID: 33512400 [TBL] [Abstract][Full Text] [Related]
6. Mild Clinical Course of COVID-19 in 3 Patients Receiving Therapeutic Monoclonal Antibodies Targeting C5 Complement for Hematologic Disorders. Araten DJ; Belmont HM; Schaefer-Cutillo J; Iyengar A; Mattoo A; Reddy R Am J Case Rep; 2020 Sep; 21():e927418. PubMed ID: 32917848 [TBL] [Abstract][Full Text] [Related]
8. Successful treatment of a PNH patient non-responsive to eculizumab with the novel complement C5 inhibitor coversin (nomacopan). Schols S; Nunn MA; Mackie I; Weston-Davies W; Nishimura JI; Kanakura Y; Blijlevens N; Muus P; Langemeijer S Br J Haematol; 2020 Jan; 188(2):334-337. PubMed ID: 31840801 [No Abstract] [Full Text] [Related]
9. A Hispanic female patient with heartburn: A rare presentation of Paroxysmal Nocturnal Hemoglobinuria. Figueroa-Jiménez LA; González-Márquez AL; Alicea-Guevara R; Santiago-Casiano M; de la Paz-López M; Negrón-Garcia L; Báez-Diaz L; Cáceres-Pérkins W Bol Asoc Med P R; 2015; 107(3):9-12. PubMed ID: 26742189 [TBL] [Abstract][Full Text] [Related]
10. Portal vein thrombosis as the first presentation of paroxysmal nocturnal hemoglobinuria. Wang R; Guo X; Tang Y; Qi X Drug Discov Ther; 2022 Sep; 16(4):200-203. PubMed ID: 35989282 [TBL] [Abstract][Full Text] [Related]
11. Detection of paroxysmal nocturnal haemoglobinuria clones in cases of deep vein thrombosis in a tertiary care centre, western Rajasthan. Passey S; Purohit A Indian J Med Res; 2022 Sep; 156(3):543-548. PubMed ID: 36751751 [TBL] [Abstract][Full Text] [Related]
12. Patients with paroxysmal nocturnal hemoglobinuria demonstrate a prothrombotic clotting phenotype which is improved by complement inhibition with eculizumab. Macrae FL; Peacock-Young B; Bowman P; Baker SR; Quested S; Linton E; Hillmen P; Griffin M; Munir T; Payne D; McKinley C; Clarke D; Newton DJ; Hill A; Ariëns RAS Am J Hematol; 2020 Aug; 95(8):944-952. PubMed ID: 32311169 [TBL] [Abstract][Full Text] [Related]
13. Paroxysmal nocturnal haemoglobinuria: an easily missed entity. Mohamed M; Koay J Med J Aust; 2021 Sep; 215(6):254-256.e1. PubMed ID: 34458985 [No Abstract] [Full Text] [Related]
14. [Paroxysmal nocturnal hemoglobinuria and thrombosis in the era of eculizumab]. Nishimura JI Rinsho Ketsueki; 2018; 59(8):1042-1047. PubMed ID: 30185704 [TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of 512 eculizumab-naive paroxysmal nocturnal hemoglobinuria patients in China: a single-center observational study. Du Y; Yang Y; Yang C; Chen M; Han B Hematology; 2022 Dec; 27(1):113-121. PubMed ID: 35068377 [TBL] [Abstract][Full Text] [Related]
16. Complement inhibition to treat myocardial infarction? Gerber B; Kyburz T; Reinhart WH; Bonetti PO; Stussi G BMJ Case Rep; 2011 Apr; 2011():. PubMed ID: 22696664 [TBL] [Abstract][Full Text] [Related]
17. COVID19 infection in a patient with paroxysmal nocturnal hemoglobinuria: A case report. Sokol J; Nehaj F; Mokan M; Lisa L; Stasko J Medicine (Baltimore); 2021 May; 100(20):e25456. PubMed ID: 34011023 [TBL] [Abstract][Full Text] [Related]
18. Learnings from over 25 years of PNH experience: the era of targeted complement inhibition. Heitlinger E Blood Rev; 2013 Dec; 27 Suppl 1():S1-6. PubMed ID: 24331206 [TBL] [Abstract][Full Text] [Related]
19. Paroxysmal nocturnal hemoglobinuria: a red clot syndrome. Crawford JD; Wong VW; Deloughery TG; Mitchell EL; Liem TK; Landry GJ; Azarbal AF; Moneta GL Ann Vasc Surg; 2014 Jan; 28(1):122.e5-10. PubMed ID: 24200143 [TBL] [Abstract][Full Text] [Related]